Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Parkinson's Disease - Autonomic Dysregulation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00103597
What this trial is testing

Efficacy of Therapeutic Interventions for Orthostatic Hypotension in Parkinson's Disease and Multiple System Atrophy

Who this might be right for
Parkinson's DiseaseMultiple System AtrophyOrthostatic Hypotension
Royal Brisbane and Women's Hospital 50
Not applicableLooking for participantsNCT06174948
What this trial is testing

The Use of the CUE1/CUE1+ in People With Parkinson's Disease and Related Disorders

Who this might be right for
Parkinson's Disease and ParkinsonismProgressive Supranuclear PalsyDifferent Types of Tremor Including Essential Tremor+5 more
Queen Mary University of London 70
Large-scale testing (Phase 3)Not Yet RecruitingNCT07825402
What this trial is testing

A Trial of ONO-2808 in Participants With the Parkinsonian Subtype of Multiple System Atrophy (MSA-P)

Who this might be right for
Multiple System Atrophy, Parkinson Variant
Ono Pharmaceutical Co., Ltd. 486
Large-scale testing (Phase 3)Ended earlyNCT03829657
What this trial is testing

Phase 3 Clinical Effect Durability of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure

Who this might be right for
Symptomatic Neurogenic Orthostatic HypotensionMSAParkinson's Disease (PD)+1 more
Theravance Biopharma 203
Not applicableLooking for participantsNCT00874783
What this trial is testing

Development of IPS from Donated Somatic Cells of Patients with Neurological Diseases

Who this might be right for
Neurodegenerative Disorders
Hadassah Medical Organization 120
Not applicableUnknownNCT02114242
What this trial is testing

Biomarkers in Parkinsonian Syndromes

Who this might be right for
Parkinsonian SyndromesParkinson's DiseaseMultiple System Atrophy+1 more
University Hospital, Bordeaux 100
Not applicableStudy completedNCT01316666
What this trial is testing

Norepinephrine Transporter Blockade as a Pathological Biomarker in Neurogenic Orthostatic Hypotension

Who this might be right for
Orthostatic HypotensionPure Autonomic FailureMultiple System Atrophy+1 more
Vanderbilt University Medical Center 50
Not applicableNot Yet RecruitingNCT07604883
What this trial is testing

Early Molecular Biomarkers for Differentiating Parkinsonian Syndromes

Who this might be right for
PARKINSON DISEASE (Disorder)Atypical ParkinsonismMultiple System Atrophy+2 more
International Institute of Molecular and Cell Biology in Warsaw 200
Not applicableStudy completedNCT06017232
What this trial is testing

Telerehabilitation for Dysautonomia in Parkinson's Disease

Who this might be right for
Parkinson Disease
Université de Sherbrooke 16
Not applicableStudy completedNCT06606743
What this trial is testing

Interval Training and Parkinson's Disease

Who this might be right for
Other Disorders of Autonomic Nervous System
University of Miami 39
Large-scale testing (Phase 3)Ended earlyNCT00211224
What this trial is testing

Neuroprotection and Natural History in Parkinson's Plus Syndromes (NNIPPS)

Who this might be right for
Multiple System AtrophyProgressive Supranuclear Palsy
King's College London 800
Not applicableActive Not RecruitingNCT06501469
What this trial is testing

Biomarkers in Parkinsonian Syndromes

Who this might be right for
Parkinson DiseaseProgressive Supranuclear PalsyMultiple System Atrophy+2 more
Non-profit organization for scientific research in Parkinson's disease and related disorders 200
Post-approval studies (Phase 4)UnknownNCT00822913
What this trial is testing

Botulinum A Toxin in Patients With Parkinson's Disease

Who this might be right for
Parkinson's DiseaseMultiple System AtrophyDetrusor Overactivity
University Of Perugia 20
Not applicableLooking for participantsNCT06203106
What this trial is testing

NYSCF Scientific Discovery Biobank

Who this might be right for
ALSAmyotrophic Lateral SclerosisAlzheimer Disease+26 more
New York Stem Cell Foundation Research Institute 10,000
Very early researchWithdrawnNCT04346394
What this trial is testing

The Role of the Noradrenergic System in the Nonmotor Symptoms of Parkinson's Disease

Who this might be right for
Parkinson Disease
Nathaniel M. Robbins
Not applicableStudy completedNCT00368199
What this trial is testing

Transcranial Duplex Scanning and Single Photon Emission Computer Tomography (SPECT) in Parkinsonian Syndromes

Who this might be right for
Parkinson's DiseaseParkinsonian SyndromeMultiple System Atrophy+4 more
Maastricht University Medical Center 196
Not applicableStudy completedNCT05638815
What this trial is testing

An Observational Study of Parkinson's Disease and Other Synucleinopathies (EASE-PD)

Who this might be right for
Parkinson's DiseaseMultiple System Atrophy
SciNeuro 89
Very early researchLooking for participantsNCT06098612
What this trial is testing

PET Imaging Evaluation of [11C]SY08

Who this might be right for
Parkinson's DiseaseMultiple System AtrophyDementia With Lewy Bodies+1 more
Massachusetts General Hospital 40
Not applicableUnknownNCT06255717
What this trial is testing

The Effect of Rehabilitation Training on Orthostatic Hypotension in Parkinson's Patients

Who this might be right for
Orthostatic Hypotension
Zeng Changhao 80
Not applicableStudy completedNCT00001549
What this trial is testing

Diagnosis and Natural History Study of Patients With Neurological Conditions

Who this might be right for
Alzheimer's DiseaseDementiaMovement Disorder+2 more
National Institute of Neurological Disorders and Stroke (NINDS) 600
Next Page